tiprankstipranks
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market
CYTOF
Altamira Therapeutics
RESEARCH TOOLSreports
Want to see CYTOF full AI Analyst Report?

Altamira Therapeutics (CYTOF) Cash flow

599 Followers

Altamira Therapeutics Cash Flow

CYTOF's free cash flow for Q2 2023 was CHF-3.86M. For the 2023 fiscal year, CYTOF's free cash flow was decreased by CHF-685.03K and operating cash flow was CHF-3.86M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
CHF -11.51MCHF -8.68MCHF -13.67MCHF -4.84MCHF -8.39M
Investing Cash Flow
CHF 1.44MCHF -2.14MCHF -3.51MCHF -2.31MCHF -3.00M
Financing Cash Flow
CHF 10.62MCHF 9.83MCHF 6.61MCHF 16.96MCHF 7.38M
End Cash Position
CHF 617.41KCHF 15.39KCHF 984.19KCHF 11.26MCHF 1.38M
Free Cash Flow
CHF -11.51MCHF -10.83MCHF -17.00MCHF -7.16MCHF -11.41M
Currency in CHF

Altamira Therapeutics Cash Flow